TSTLTristel plc
380.00GBp-0.65%Mkt Cap: 182.35M GBpP/E: 23.75Last update: 2026-06-01

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical De…

Indicators:|

Key Statistics

Company
Market Cap182.35M GBp
Enterprise Value175.16M GBp
Revenue (TTM)49.54M GBp
Gross Profit37.46M GBp
Net Income (TTM)6.64M GBp
Revenue/Share1.038 GBp
Last Price380.00 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees270
CountryGB
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN
Valuation
P/E (Trailing)23.75
P/E (Forward)18.72
PEG
EV/EBITDA15.30
EV/Revenue3.54
P/S3.71
P/B5.44
EPS (TTM)0.16
EPS (Forward)0.20
52W Range
340.0038% of range445.00
52W High445.00 GBp
52W Low340.00 GBp
Profitability
Gross Margin80.62%
Oper. Margin19.71%
EBITDA Margin23.12%
Profit Margin14.29%
ROE20.13%
ROA14.65%
Growth
Revenue Growth13.60%
Earnings Growth42.40%
Cash Flow & Leverage
Operating CF10.32M GBp
CapEx (TTM)1.98M GBp
FCF Margin14.30%
FCF Yield3.88%
Net Debt-7.46M GBp
Net Debt/EBITDA-0.65
Balance Sheet
Debt/Equity0.18
Current Ratio4.13
Quick Ratio3.45
Book Value/Sh0.7030 GBp
Cash/Share0.2780 GBp
Dividends
Fwd Div Rate0.1400 GBp
Trail. Div Rate0.1420 GBp
Div. Yield3.81%
5Y Avg Yield2.51%
Payout Ratio87.44%
Ex-Div DateMar 19, 2026
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)472.33 GBp
Target Range400.00 GBp560.00 GBp
# Analysts6
Ownership
Shares Out.47.99M
Float46.10M
Insiders2.40%
Institutions45.37%
Technical
SMA 50385.23 (-1.4%)
SMA 200384.71 (-1.2%)
Beta0.34
S&P 52W Chg27.94%
Avg Vol (30d)176.58K
Avg Vol (10d)190.79K
Technical Indicators
RSI (14)44.7
MACD-2.7402
MACD Signal0.5672
MACD Hist.-3.3073
BB Upper423.96 GBp
BB Middle396.95 GBp
BB Lower369.94 GBp
BB Width13.61%
ATR (14)16.46 GBp
Vol Ratio (20d)6.64x